Treatment of human taeniasis in the Philippines: a review.
dc.contributor.author | Cruz, A C | en_US |
dc.date.accessioned | 2009-05-27T14:43:04Z | |
dc.date.available | 2009-05-27T14:43:04Z | |
dc.date.issued | 1991-12-01 | en_US |
dc.description | The Southeast Asian Journal of Tropical Medicine and Public Health. 11 references. | en_US |
dc.description.abstract | Studies relating to the treatment of human taeniasis in the Philippines using Atabrine, bithionol, and mebendazole are reviewed. Cure rates of 93.7% for Atabrine, 85%-100% for bithionol, and 84.62% for mebendazole are reported. Aside from these studies, recent experience in the treatment of Taenia saginata infections at the Department of Parasitology, College of Public Health, is also reported. Twenty patients referred to the department were treated, 3 with bithionol, 17 with praziquantel. Of the 17 patients treated with praziquantel, the study reported cure rates of 47-88.24%. | en_US |
dc.description.affiliation | Department of Parasitology, College of Public Health, University of the Philippines, Manila. | en_US |
dc.identifier.citation | Cruz AC. Treatment of human taeniasis in the Philippines: a review. The Southeast Asian Journal of Tropical Medicine and Public Health. 1991 Dec; 22 Suppl(): 271-4 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/30891 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.tm.mahidol.ac.th/seameo/publication.htm | en_US |
dc.subject.mesh | Bithionol --therapeutic use | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Mebendazole --therapeutic use | en_US |
dc.subject.mesh | Philippines | en_US |
dc.subject.mesh | Praziquantel --therapeutic use | en_US |
dc.subject.mesh | Quinacrine --therapeutic use | en_US |
dc.subject.mesh | Taeniasis --drug therapy | en_US |
dc.title | Treatment of human taeniasis in the Philippines: a review. | en_US |
dc.type | Journal Article | en_US |
dc.type | Review | en_US |
Files
License bundle
1 - 1 of 1